Oruka Therapeutics ORKA
NASDAQ ORKA
$84.52 +1.10 (+1.32%)
At close: Oct 2, 2026 · 4:00 PM EDT

Oruka Therapeutics (ORKA) Interest & Investment Income (2010 - 2024)

Updated

Oruka Therapeutics (ORKA) posted Interest & Investment Income of $444,000 for Q2 2024, down 9.9% from $493,000 a year earlier and down 6.1% from the prior quarter.

Analysis

Oruka Therapeutics (ORKA) Interest & Investment Income (2010 - 2024) Analysis & Trends

For the trailing twelve months through Jun 30, 2024, Interest & Investment Income at Oruka Therapeutics was $1.93 million, up 25.5% year-over-year; for FY2023, it came in at $1.96 million, up 189.9% from FY2022.

  • Annual Interest & Investment Income shows a five-year compound annual growth rate of 64.6% (FY2018 to FY2023).
  • In prior years, Oruka Therapeutics' Interest & Investment Income was $675,000 in FY2022, $13,000 in FY2021 (-53.6%), $28,000 in FY2020 (-83.7%) and $172,000 in FY2019 (+6.2%).
  • The Q2 2024 figure stands as the lowest quarterly Interest & Investment Income since Q4 2022.
  • On a year-over-year basis, Interest & Investment Income increased in four of the last five quarters, with growth averaging 149.0%.
  • The strongest year-over-year quarter for Interest & Investment Income in the past five years was Q2 2023, with growth of 584.7%; the weakest was Q3 2020, with a decline of 98.0%.
  • According to Business Quant data, Interest & Investment Income for the three prior quarters was $473,000 (Q1 2024), $501,000 (Q4 2023) and $513,000 (Q3 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Oruka Therapeutics 5.31 Bn 3.37 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 444,000.00
Mar 31, 2024 473,000.00
Dec 31, 2023 501,000.00
Sep 30, 2023 513,000.00
Jun 30, 2023 493,000.00
Mar 31, 2023 450,000.00
Dec 31, 2022 374,000.00
Sep 30, 2022 222,000.00
Jun 30, 2022 72,000.00
Mar 31, 2022 7,000.00
Dec 31, 2021 4,000.00
Sep 30, 2021 4,000.00
Jun 30, 2021 3,000.00
Mar 31, 2021 2,000.00
Dec 31, 2020 1,000.00
Sep 30, 2020 1,000.00
Jun 30, 2020 2,000.00
Mar 31, 2020 24,000.00
Dec 31, 2019 36,000.00
Sep 30, 2019 50,000.00
API Access

Oruka Therapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ORKA&period=max&api_key=YOUR_API_KEY